M&A Deal Summary |
|
---|---|
Date | 2020-02-26 |
Target | InstruNor AS |
Sector | Life Science |
Buyer(s) | Standard BioTools |
Deal Type | Add-on Acquisition |
Deal Value | 7M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1999 |
Sector | Life Science |
Employees | 534 |
Revenue | 106M USD (2023) |
Standard BioTools is an industry's major biotechnology tools provider with a vision to improve life through comprehensive health insight. Fluidigm Corp. focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions and accelerate the development of more effective therapies. Standard BioTools was founded in 1999 and is based in South San Francisco, California.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
Country (Norway) | 1 of 1 |
Year (2020) | 1 of 1 |
Size (of disclosed) | 1 of 1 |